Pfizer Inc.
View all documents by Pfizer Inc.Company Overview
Pfizer Inc. discovers, develops, manufactures and markets leading prescription medicines for humans and animals and many of the world's best-known consumer brands. Our innovative, value-added products improve the quality of life of people around the world and help them enjoy longer, healthier and more productive lives. The company has three business segments: health care, animal health and consumer health care. Our products are available in more than 150 countries.
Quick Facts
Pfizer Inc.
235 E. 42nd St.
New York, NY 10017
- White Papers/Case Studies (3)
- Analyst Reports (0)
- Webcasts (0)
- Multimedia (0)
- Application Notes (0)
- Product Information (0)
.
WHITEPAPERS/CASE STUDIES
- Mea culpa by a big pharma CEO by Pfizer Inc.
Dr. Peter Rost, vice president of marketing for Pfizer Inc., reviews A Call to Action, a book by his boss, Pfizer CEO Hank McKinnell, about the pharmaceutical industry.
- Getting past the legal hurdles of a global digital signature standard by Pfizer Inc.
This white paper from Pfizer Inc. describes the SAFE-Biopharma Association initiative to create a platform based on digital signatures that would preserve the security of intellectual property, business transactions and records.
- HHS importation study draws the wrong conclusions by Pfizer Inc.
The 2005 Health and Human Services (HHS) study on drug reimportation estimated that total savings from legalized commercial importation would only be one to two percent of total drug spending. This Pfizer Inc. white paper argues that it's much higher.
